Delivery Order SPE2DB20D2014-SPE2DB25FD00K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a contract value of $2,836.90. The award, made on September 11, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025. This contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work from its corporate office...
- The Defense Logistics Agency (DLA) awarded a $2,917.12 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count containers) with a ceiling value of $1,339.92. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count) with a ceiling value of $1,274.82. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, carries no set-aside designation and represents a competitively awarded transaction. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a ceiling value of $1,643.89. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a direct procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a contract ceiling value of $11,475.72. This firm fixed-price delivery order, which is due for completion by August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,695.44 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 12, 2025, with completion expected by September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and was awarded competitively. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD00KDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units) with a ceiling value of $2,332.93. This firm fixed-price delivery order, which extends through September 16, 2025, represents a competitive award with no set-aside designation. The contract will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, serving the federal government's pharmaceutical procurement requirements for military and healthcare system use. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, leverages this comprehensive IDC vehicle to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. The company's federal contract portfolio reflects consistent competitively awarded business across multiple therapeutic domains, positioning it as a critical vendor within the federal medical supply chain for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/15/25 |